From Disclosure to Decision: How AI-Guided Navigation and Aligned Incentives Unlock the Promise of Healthcare Price Transparency

1. Introduction

Healthcare price transparency has become one of the rare policy areas commanding bipartisan political support. In December 2023, the U.S. House of Representatives passed the Lower Costs, More Transparency Act by a vote of 320 to 71.¹ Nearly nine out of ten Americans express support for healthcare price transparency.² The logic is intuitive: if patients can see prices, they will shop for lower-cost care; if providers compete on price, costs will fall and quality will improve.

The evidence, however, tells a more complicated story.

New Hampshire launched one of the country's first public healthcare price transparency websites, advertised it broadly, and achieved a utilization rate of approximately 1% of eligible consumers within three years of launch.³ Six months after federal hospital price transparency rules took effect on January 1, 2021, 55% of Medicare-certified hospitals had not posted readable pricing files.⁴ Even among compliant hospitals, the posted prices were only machine-readable, structured inconsistently, and nearly impossible for an average consumer to translate into what they would personally owe, no matter their specific insurance plan and deductible status.

This is not an argument against price transparency. It is an argument that price disclosure alone — absent the tools, incentives, and structural conditions that enable consumers to act on that information — would not produce the market efficiency its architects intended.

This paper proposes that effective healthcare price transparency requires a five-component framework: (1) AI-guided care navigation; (2) consumer-facing price intelligence presenting all relevant price tiers; (3) employer-side cost intelligence; (4) steerage incentives that persist across the full insurance year; and (5) primary care incentive alignment through Direct Primary Care. We further identify consumer financing bridges as a critical enabler of high-deductible plan adoption.

2. The Insurance Design Failure: How Coverage Became the Cost Driver

Understanding why price transparency is necessary starts with an understanding of how health insurance in America came to be structured differently from every other insurance product Americans use.

Car insurance does not pay for flat tires or oil changes. Homeowners insurance does not pay for lawn maintenance. These products are designed to cover catastrophic, unforeseeable events — not routine maintenance that the insured can plan and pay for directly. Coverage for predictable, manageable expenses removes the consumer's incentive to seek value, inflating demand and prices alike. The economic term for this dynamic is moral hazard, described formally by Pauly (1968): when the cost of a good or service is born by a third party rather than the consumer, demand expands beyond what the consumer would purchase if paying directly.¹⁷

The $5 copay and the utilization surge. In the early 1990s, Health Maintenance Organizations gained market share rapidly on the premise of coordinated, preventive care. To remove utilization barriers, HMOs introduced near-zero copayments — typically $5–$10 per visit. What followed was predictable in retrospect. At near-zero cost to the patient, demand for healthcare services increased substantially. Volume increased. Utilization ratios rose. Premiums followed.

The empirical evidence is rigorous and largely settled. The RAND Health Insurance Experiment — the most comprehensive randomized study of health insurance design ever conducted — enrolled approximately 2,000 families from 1974 to 1982 and assigned them to plans with varying cost-sharing levels.¹⁸ The findings were unambiguous: families with free coverage consumed 30% more physician visits and 28% more inpatient admissions than those facing significant cost-sharing. The elevated utilization applied to both necessary and unnecessary care proportionally.

The HDHP overcorrection. As premiums climbed through the 1990s and 2000s, employers shifted costs to employees through high-deductible health plans. HDHPs restored financial accountability — but the pendulum overcorrected. A $6,000 family deductible does not merely discourage unnecessary office visits; it discourages necessary ones. Surveys of HDHP enrollees have found that 43% reported deferring or skipping recommended care because of cost.¹⁹ Separately, 61.6% of HDHP enrollees reported having no Health Savings Account in place to buffer deductible exposure.²⁰

The design principle that was lost: Health insurance functions optimally when it operates on the same philosophical basis as all other insurance products: cover the catastrophic, unforeseeable event — cancer, cardiac surgery, major trauma — and allow consumers to manage predictable, plannable expenses through direct market transactions at transparent prices. Primary care visits, routine imaging, laboratory work, and generic medications are not the “wrecks” so to speak, they are the “oil changes”.

3. The State of Price Transparency: Compliance Without Consequence

The resulting compliance landscape has been mixed at best. For identical services, commercial insurance prices frequently reach 224% of Medicare-allowable rates.⁸ Hospital colonoscopies cost approximately 55% more than ambulatory surgery centers in the same county for clinically equivalent procedures.⁹ Cash prices are lower than insurance negotiated rates in 47% of studied instances — meaning insured patients who simply paid cash would have spent less.¹⁰ This variation is real and large. But a patient presented with these figures — without guidance on which applies to their specific plan and year-to-date deductible accumulation — cannot make an informed decision.

The “multi-price” problem. Most consumers are unaware that healthcare services have not just one rate, but are convoluted by at least four ways to pay: the hospital chargemaster rate, the insurance negotiated rate, the cash-pay rate — and as of late a fourth tier: international facilities that perform procedures at a 65–80% savings relative to US network rates.

4. Why Price Lists Fail: The Documented Barriers to Healthcare Shopping

The academic literature has identified five categories of barriers that prevent price transparency from producing market efficiency, even when prices are technically accessible.³

Consumer awareness. Most patients do not know that price variation exists at the scale it does, do not know that cash prices are available to insured patients, and do not know that price transparency websites exist. Even in markets with well-publicized transparency programs, utilization rates remain low.

Inability to compare "apples to apples." A single procedure involves multiple billing events — facility, surgeon, anesthesiologist, pathologist, follow-up — each potentially processed separately. A patient asking "what will this cost me?" needs a personalized, plan-aware answer that accounts for their year-to-date deductible, their carrier's negotiated rate at each facility, and the difference between bundled and unbundled billing models.

Provider relationship friction. Patients have established relationships with primary care physicians who refer to specific specialists and facilities. Choosing a different facility — even a dramatically lower-cost one — requires coordinating records transfer and navigating a new provider relationship. The opportunity cost of this coordination is real and measurable.

Poor incentive structure. Once a patient has met their annual deductible, they have no personal financial incentive to choose a lower-cost facility. The insurance company pays the marginal cost either way. Steerage programs that incentivize cost-conscious choices only during the deductible period therefore fail to capture the majority of high-cost procedures.

Deficiency of actionable quality information. Price and quality are not the same. A lower-cost facility is only attractive if the consumer can verify that it delivers comparable clinical outcomes. Most transparency tools present price without quality context.

5. What the Evidence Says Works

Despite these barriers, several studies demonstrate that consumers can respond to price information when the conditions are right.

Whaley et al., analyzing 2017–2018 employer-sponsored plan data, found that prices decreased for beneficiaries who received a financial payment to choose care from lower-cost providers. Effects were most concentrated in imaging — specifically MRI — where price variation is large and the service is highly shoppable.¹¹ The critical insight: the combination of transparency and a financial incentive was necessary. Neither alone was sufficient.

Christensen et al. reported that hospitals responded to price transparency regulation by lowering their prices, hypothesizing that hospitals were sensitive to the reputational risk of being publicly identified as high-price outliers.¹² This suggests transparency affects not only consumer behavior but also provider pricing behavior.

6. A Framework for Navigation-Enabled Price Transparency

The framework described in this paper is built on the premise that price disclosure requires a navigation layer to produce behavior change. It integrates five components, each designed to address a documented barrier to healthcare shopping.

6.1 The Coming of Age of AI

With the increase in proficiency of Artificial Intelligence, it has become feasible for LLM AI tools to be inserted at the center of the platform. Rather than presenting a price list, AI conducts a structured dialogue that identifies the consumer's specific situation — insurance status, year-to-date deductible accumulation, location, and care need — and returns a personalized recommendation across all relevant price tiers.

The AI navigation layer addresses the awareness barrier by proactively surfacing the cash-pay option for every procedure search. It addresses provider relationship friction by surfacing the facility's direct contact information, scheduling link, and a superbill template the consumer can submit to their insurer for out-of-network credit. The navigation layer also functions as a pre-visit triage layer: published literature suggests that 20–30% of emergency department visits could be safely managed in lower-cost settings.¹³

6.2 Consumer-Facing Price Intelligence

The framework's price intelligence component presents prices across four tiers:

1. Highest in-network rate — the consumer's carrier at the identified facility
2. Lowest in-network rate — the best available network option
3. Best US cash price — aggregated from 40+ transparent-pricing ambulatory surgery centers that publish bundled all-in prices
4. Best international price — JCI-accredited international facilities with all-in pricing inclusive of surgical, anesthesia, and facility fees

Each result includes quality signals drawn from CMS Hospital Compare star ratings, Leapfrog safety grades, CMS Value-Based Purchasing scores, HCAHPS patient survey results, and — for international facilities — PubMed publication counts for the treating surgeons as a proxy for academic credential and case volume.

6.3 Employer-Side Cost Intelligence

For self-funded employers, the platform ingests claims data from 30+ TPA file formats and applies 40 evidence-based clinical algorithms to identify avoidable spending. Algorithms cover avoidable emergency department visits, hospital outpatient vs. ambulatory surgery center site-of-service arbitrage, brand-name prescription opportunities for generic substitution, duplicate imaging, medication safety gaps, chronic condition management gaps, and preventive care deficiencies.

All employer-facing reporting is aggregate only. No individual member is identified in any output. Cohorts with fewer than 10 members are suppressed.

6.4 Steerage Incentives That Persist Across the Deductible Cycle

The framework models five employer-funded steerage incentive programs:

1. Deductible waiver — employer waives the employee's deductible for procedures at designated cash-pay facilities
2. Shared savings — employee receives 25–50% of documented savings when choosing a cash-pay facility over the in-network hospital
3. Interest-free cash advance — employer advances the cash-pay facility price, repaid through payroll deduction over 6–12 months
4. HRA pre-fund — employer pre-funds a Health Reimbursement Arrangement for employees who commit to high-value cash facilities
5. Direct Primary Care subsidy — employer covers the DPC practice membership fee as a benefit-in-kind

The critical design principle: shared savings incentives must apply regardless of where the employee is in their deductible cycle. An employee who has met their $3,000 deductible has no personal financial incentive to choose a $4,000 cash-pay knee replacement over a $28,000 network hospital — insurance pays either way. An employer-funded shared savings payment of $500–$1,000 for choosing the surgery center restores that incentive. The employer still saves $23,000–$24,000 on the claim net of the incentive payment.

6.5 Primary Care Incentive Alignment: The Direct Primary Care Model

The fee-for-service model creates a structural misalignment in primary care that no price transparency initiative can correct at the margins. A primary care physician in a traditional practice requires approximately 2,000 panel patients to generate sustainable revenue. Income is directly correlated with patient visit volume — which means a physician who resolves a patient's chronic condition loses revenue.

Direct Primary Care eliminates this misalignment. Physicians charge a monthly subscription fee ($50–$100 per patient) and cap their panels at 200–400 patients. Revenue is not tied to visit volume. Published literature finds that DPC adoption reduces emergency department visits, specialist referrals, and imaging utilization by 20–40%.¹⁴

7. Consumer Financing as an HDHP Adoption Bridge

High-deductible health plans represent the most economically rational option for many consumers and employer groups: premiums are dramatically lower, and the associated HSA tax advantage is — as financial planners increasingly note — the most favorable account structure in the US tax code. An HSA allows pre-tax contributions, tax-free investment growth, and tax-free withdrawals for qualified medical expenses: a triple tax advantage available in no other account type.¹⁵

Yet HDHP adoption faces a specific behavioral barrier: the deductible. Deferred-interest healthcare financing (e.g., CareCredit) provides the bridge. A consumer who experiences a $3,000 medical event in February of their first HDHP year can finance that expense at 0% interest for 12–24 months while their HSA accumulates. Their premium savings ($200/month) more than covers the financing payment. By year two, the HSA carries a meaningful balance that makes deductible exposure manageable without financing.

8. Policy Implications

Compliance without usability is insufficient. The current price transparency enforcement regime focuses on whether prices are posted, not whether they are usable. Usability standards — not just disclosure standards — are the missing regulatory element.

Incentive design belongs in federal guidance. The Whaley et al. findings on financial incentives for lower-cost provider choice should inform CMS guidance on HDHP and HSA plan design. Clear safe harbor provisions for employer steerage incentive programs that persist across the deductible cycle would accelerate adoption.

DPC integration with employer benefits requires regulatory clarity. DPC membership fees are not currently reimbursable from HSA funds. Legislative clarification that DPC membership fees qualify as HSA-eligible medical expenses would materially accelerate the incentive alignment described in this paper.

AI navigation raises questions of accountability. The AI navigation component is designed as a navigation and cost intelligence tool, not a clinical decision-support system, and does not provide diagnoses or treatment recommendations. Clear guidance from CMS and FDA on the boundary between care navigation AI and clinical decision-support AI would provide the market clarity needed for responsible deployment at scale.

9. Conclusion

The current healthcare price transparency regime has produced compliance without consequence. Prices are posted. Consumers are not shopping. Costs continue to rise.

Price transparency matters more than the healthcare pricing debate has fully acknowledged, because transparency is the prerequisite for everything else. Without visible, comparable, usable prices, consumer behavior cannot change. Without consumer behavior change, providers have no market signal to compete on price. Without price competition, the cost structure of the healthcare system remains untouched regardless of what else changes at the policy level.

The architecture this paper describes — transparent pricing paired with AI-guided navigation, durable steerage incentives, and a primary care model that aligns physician incentives with patient health — is designed to restore the conditions that make a healthcare market function. At scale, this has market-wide implications that extend beyond any individual platform or employer group. When a sufficient volume of consumers consistently chooses lower-cost, high-value facilities, providers face a genuine competitive signal. Prices fall for everyone — including consumers who never used a price transparency tool to find them.

The oil change and the flat tire do not belong on your insurance policy. They never did. The work of restoring the healthcare market to a functioning system is the work of rebuilding the conditions — transparent prices, tools to act on them, incentives to do so — that make that separation rational and possible. That is the work.